Fairway Wealth »

Vertex Pharmaceuticals Incorporated shares owned by Fairway Wealth

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Fairway Wealth from 13F filings

Historical chart of Fairway Wealth investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Fairway Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Fairway Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.5k 13 496.69
2024-12-31 $5.6k 14 402.71
2024-06-30 $11k 24 468.71

More positions owned by Fairway Wealth

Vanguard S&p 500 Etf Etf (VOO)
Powershares Qqq Tr Etf (QQQ)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Ishares S&p 500 Index Etf (IVV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Wisdomtree Large Cap Dividend Etf (DLN)
Vanguard Extended Market Etf Etf (VXF)
Ishares S&p Smallcap 600 Etf Etf (IJR)
Vanguard Short Term Infl-protected Etf (VTIP)
Ishares Core Msci Eafe Etf (IEFA)
Ishares Core S&p Mid Cap Etf Etf (IJH)
Rpm Intl Stock (RPM)
Ishares Core Msci Emerging Mkts Etf (IEMG)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Vanguard Total International Bond Etf Etf (BNDX)

View all positions for Fairway Wealth

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Franklin Resources
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated